Overview
- Completely updated with new chapters
- Each section is self contained
- Can be used as a course textbook, reference or by chapter
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (26 chapters)
-
Front Matter
-
Pharmaceutical Biotechnology: The Science, Techniques, and Important Concepts
-
Front Matter
-
-
Pharmaceutical Biotechnology: Oligonucleotides, Genes and Cells/Cell Subunits, Vaccines—The Science, Techniques, and Clinical Use
-
Front Matter
-
Keywords
About this book
This introductory text explains both the basic science, production, quality, dosage forms, administration, economic and regulatory aspects and the clinical applications of biotechnology-derived pharmaceuticals. It serves as a complete one-stop source for undergraduate/graduate pharmacists and pharmaceutical science students. An additional important audience are pharmaceutical scientists in industry and academia, particularly those who have not received formal training in pharmaceutical biotechnology and are inexperienced in this field. The rapid growth and advances in the field made it necessary to revise this textbook in order to continue providing up-to-date information and introduce readers to cutting edge knowledge and technology of this field. This Sixth Edition completely updates the previous edition and includes additional coverage on new approaches such as oligonucleotides, siRNA, mRNA, gene therapy, cell therapies, monoclonal antibodies and vaccines. With more than 3-million-chapter downloads, the fifth edition of the textbook has achieved widespread distribution as a key educational resource for the field of pharmaceutical biotechnology.
Editors and Affiliations
About the editors
Daan J.A. Crommelin is Professor Emeritus, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherland. He is an elected fellow of the International Pharmaceutical Federation (FIP) and the American Association of Pharmaceutical Scientists (AAPS).
Robert D. Sindelar is a Professor and Dean Emeritus, Faculty of Pharmaceutical Sciences, The University of British Columbia (UBC). He is an elected fellow of the Canadian Academy of Health Sciences, and an elected fellow of the International Pharmaceutical Federation (FIP). He previously served as Vice President of Innovation, Research & Academic Affairs at Providence Health Care (PHC), President of the PHC Research Institute and Associate Dean Research in the UBC Faculty of Medicine
Bernd Meibohm is Distinguished Professor, Associate Dean for Research and Graduate Programs, and Chair of the Department of Pharmaceutical Sciences at the University of Tennessee Health Science Center College of Pharmacy, Memphis, Tennessee, USA. He is an elected fellow of the American College of Clinical Pharmacology (ACCP) and the American Association of Pharmaceutical Scientists (AAPS).
Bibliographic Information
Book Title: Pharmaceutical Biotechnology
Book Subtitle: Fundamentals and Applications
Editors: Daan J. A. Crommelin, Robert D. Sindelar, Bernd Meibohm
DOI: https://doi.org/10.1007/978-3-031-30023-3
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2024
Hardcover ISBN: 978-3-031-30022-6Published: 30 January 2024
Softcover ISBN: 978-3-031-30327-2Due: 01 March 2024
eBook ISBN: 978-3-031-30023-3Published: 29 January 2024
Edition Number: 6
Number of Pages: XXV, 682
Number of Illustrations: 14 b/w illustrations, 245 illustrations in colour
Topics: Pharmaceutical Sciences/Technology, Biotechnology, Pharmacology/Toxicology, Biomedicine, general, Biotechnology, Biotechnology